Industries > Pharma > In Vivo CRO Market Report 2019-2029

In Vivo CRO Market Report 2019-2029

Analysis by Product (Rodent, Non-Rodent), by Application (Hospitals, Clinics, Others) and by Region (North America, Europe, Asia Pacific, Latin America, MEA), Company and Country Analysis and Forecasts

PUBLISHED: 21 June 2019
PAGES: 166
PRODUCT CODE: PHA0450
SUBMARKET: Biotechnology

Clear
WOOCS 2.2.1
DOWNLOAD SAMPLE
SKU: PHA0450 Categories: , Tag:

Market Definition:
• A contract research organization (CRO) is a company that contribute support to the biotechnology, pharmaceutical and medical device industries in the form of research services outsourced on a contract basis. In Vivo CRO means preclinical testing for disease pathology and drug discovery.
• CROs are created to decrease costs for companies developing new medicines and drugs in niche markets. The objective of the company is to simplify entry into drug markets and simplify development. CROs also help research institutions, foundations, universities and to governmental organizations such as the EMA, NIH, etc.

Market Overview and Trends
• CRO provides a various service such as clinical research, biologic assay development, biopharmaceutical development, preclinical research, clinical trials management, commercialization and pharmacovigilance.
• As drug manufacturers increases their pipeline products to manufacture and introduce new molecule to sustain in market with good profit and with a patent product, vivo contract research organization market is expanding.
• The use of Contract Research Organization services helps to manufacturers and to give complete concentration on their business production capacity and also to develop and enhance their in-house processes.

Market Dynamics:

Factors Influencing the Market Growth:
• The key factor responsible for the growing demand for the CROs in pharmaceutical drug development segment is that the drug manufacturer requires CRO to investigate and collect sufficient data to invent new drug in the market.
• The increasing numbers of cancer patients, accessibility to government investment for R&D services, and increasing knowledge regarding cancer by CROs are the factors responsible for the successful growth of the market.
• Few important facts rendering the growth of the global oncology based in-vivo CRO market are due to advancement in the field of hereditary, efforts towards researching the oncogene and burgeoning issues of pharmaceutical key players towards optimizing their R&D findings.
• Vivo (CRO) market is also increasing as it saves the time of industries and make product available in market in minimum time.

Factors Restraining the Market Growth:
• The factors restraining the market growth are quality issue of the CRO, huge cost for the clinical trials and presence of suitable animal for specific tests.

Market Segmentation 2019-2029:
The In Vivo CRO market is segmented on the product, application and region.

1. In Vivo CRO, by Product
a) Rodent
b) Non-Rodent

2. In Vivo CRO, by Application
c) Hospitals
d) Clinics
e) Others

3. In Vivo CRO, by Region
a) North America
– US
– Canada
b) Europe
– Germany
– UK
– France
– Rest of Europe
c) Asia Pacific
– Japan
– China
– India
– Rest of Asia Pacific
d) Rest of the World (RoW)

Competitive Analysis:
• Research and development are the primary strategy adopted by the key players in the Global Biodefense market.
• These companies have developed various strategies and developments such as product launch, partnerships, mergers & acquisitions, joint venture, and collaborations.

Major Market Players:
Quintiles, Charles River Laboratories, ICON Plc, Covance Inc., Parexel International, Pharmaceutical Product Development, LLC (PPD), Theorem Clinical research, inVentiv Health, WuXi AppTec, Inc., American Preclinical Services, LLC. and other players

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Do you have any custom requirements we can help you with? Any need for specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com

Download sample pages

Complete the form below to download your free sample pages for In Vivo CRO Market Report 2019-2029


Download sample pages

Complete the form below to download your free sample pages for In Vivo CRO Market Report 2019-2029


Latest Pharma news

“Global Influenza Vaccines Market Set to Grow to $4.9bn by 2024” says new Visiongain report

The global vaccines market is one that is driven by innovation. This is vital for maintaining the rich pipeline of vaccines seen in the human vaccines market.

05 July 2019

READ

“Pharmaceutical Wholesale & Distribution Organizations 2019 is estimated to reach $1.4bn in 2024” says Visiongain report

Opportunities in the market stem from the increasing use of specialist and generic drugs, which have higher profit margins; global expansion into the emerging markets; vertical integration of wholesalers; and the increasing use of pharmaceuticals.

28 June 2019

READ

“Global Vaccines Sales market set to grow to $75bn by 2024” says new Visiongain report

Progress in R&D in the therapeutic vaccine field will yield revolutionary results and answer unmet medical needs. This will also lead to more innovative approaches to vaccine development.

25 June 2019

READ

“Global Inflammatory Bowel Diseases (IBD) Drug Market is estimated to reach $8.6bn by 2024” says new Visiongain report

Revenue growth will be driven by rising incidence and prevalence owing to modern lifestyles and improved awareness and diagnosis.

21 June 2019

READ

Categories

Category